Lithium Ion

Lithium Ion

SCHEMBL193641

O=S(=O)([O-])C=Cc1ccccc1.[Li+]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.52
LMNA P02545 3/20 0.52
NFE2L2 Q16236 2/20 0.52
PKM P14618 1/20 0.44
KMT2A Q03164 1/20 0.44
MAOB P27338 1/20 0.44
FBP1 P09467 1/20 0.43
HSP90AA1 P07900 2/20 0.43
MAPK1 P28482 2/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 2/20 0.43
TRPA1 O75762 1/20 0.43
ALOX5 P09917 1/20 0.43
PTGES2 Q9H7Z7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL193640 1.00 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
Lithium Ion SCHEMBL4342322 1.00 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL11600944 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL4339905 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL6436967 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL6439767 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL3002303 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL2138985 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL1565614 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A
SCHEMBL2997852 0.95 PPARG (0.52) PPARGLMNANFE2L2PKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4707313-A1 POLYMER ELECTROLYTE, SECONDARY BATTERY AND ELECTRICAL DEVICE AESC Japan Ltd. (JP) 2026-03-11 EP claimed
US-20260066344-A1 POLYMER ELECTROLYTE, SECONDARY BATTERY AND ELECTRICAL DEVICE AESC JAPAN LTD. (JP) 2026-03-05 US claimed
EP-3600628-B1 ION-EXCHANGE MEMBRANE HAVING AN IMPRINTED NON-WOVEN SUBSTRATE BL TECHNOLOGIES INC (US) 2025-05-07 EP claimed
CN-118100347-B Battery charging control method, device and system 佛山市佳盈电池有限公司 2025-03-25 CN claimed
CN-119406259-A Single-molecule bipolar ion exchange membrane containing dissociation-promoting layer and preparation method thereof 孟广祯 2025-02-11 CN claimed
US-12218356-B2 Composition for non-aqueous secondary battery functional layer, battery member for non-aqueous secondary battery, method of producing laminate for non-aqueous secondary battery, and non-aqueous secondary battery ZEON CORPORATION (JP) 2025-02-04 US claimed
CN-118899529-A Polymer electrolyte, secondary battery, and electricity using device 株式会社AESC日本 2024-11-05 CN claimed
CN-118841534-A Sulfonic acid modified positive electrode material and preparation method and application thereof 广东邦普循环科技有限公司 2024-10-25 CN claimed
CN-118460147-A Preparation method and application of polyacrylic acid powder binder for lithium battery 杭州叁元素赋能新材料有限公司 2024-08-09 CN claimed
EP-3931272-B1 WATER WASHABLE THERMAL AND PLASMA RESISTANT COATING FOR LASER INTERACTIVE APPLICATIONS MOORE JOHN CLEAON (US) 2024-07-17 EP claimed
US-7250234-B2 Lithium battery with retained gel-electrolyte CALEB TECHNOLOGY CORPORATION (US) 2007-07-31 US claimed
CN-1245771-C Lithium battery with retained gel-electrolyte CALEB TECHNOLOGY CORP (US) 2006-03-15 CN claimed
US-20010009967-A1 Styrene sulfonate cation exchange membrane UBS AG, STAMFORD BRANCH AS COLLATERAL AGENT 2001-07-26 US claimed
US-6221248-B1 CROSSLINKING MONOMER AND METAL STYRENESULFONATE AND SOLVENTS, POTASSIUM OR SODIUM SALTS IONICS INCORPORATED 2001-04-24 US claimed
EP-1066331-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS INCORPORATED (US) 2001-01-10 EP claimed
WO-1999048940-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS, INCORPORATED (US) 1999-09-30 WO claimed
EP-0592575-B1 ORGANIC-INORGANIC POLYMERIC COMPOSITES DU PONT (US) 1998-03-18 EP claimed
WO-1997018423-A1 POLYMER ENHANCED GLYCOL DESICCANT HEAT-PIPE AIR DEHUMIDIFIER PRECONDITIONING SYSTEM MECKLER MILTON (US) 1997-05-22 WO claimed
US-5471852-A Polymer enhanced glycol desiccant heat-pipe air dehumidifier preconditioning system DESIGN BUILD SYSTEMS 1995-12-05 US claimed
US-5087602-A Developer polymer from styrene monomer, and either vinylsulfonic acid type monomer (meth) acrylic type phosphorus-containing monomer and or (meth) acyrlic acid type manomers MITSUBISHI PAPER MILLS LIMITED (JP) 1992-02-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260066344-A1 POLYMER ELECTROLYTE, SECONDARY BATTERY AND ELECTRICAL DEVICE LDHB, CACNB3, EPHB3 PPARG 2551/4885LMNA 416/4885NFE2L2 4006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.